197 related articles for article (PubMed ID: 9475921)
1. Drugs causing prolongation of QT interval and torsades de pointes.
CMAJ; 1998 Jan; 158(1):103-4, 107-8. PubMed ID: 9475921
[No Abstract] [Full Text] [Related]
2. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.
Pearson EC; Woosley RL
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):747-53. PubMed ID: 15918160
[TBL] [Abstract][Full Text] [Related]
3. [Long QT and torsades de pointes as adverse effects of drugs].
Jensen K
Ugeskr Laeger; 2000 Oct; 162(42):5654. PubMed ID: 11059311
[No Abstract] [Full Text] [Related]
4. [Adverse drug reactions. QT-prolongation and torsade-de-pointes arrhythmias].
Haffner S; Lapp H; Thürmann PA
Dtsch Med Wochenschr; 2002 May; 127(19):1022-4. PubMed ID: 11997870
[No Abstract] [Full Text] [Related]
5. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake.
Yalta K; Turgut O; Yilmaz A; Yilmaz MB; Kendirlioglu O; Karadas F
Int J Cardiol; 2007 Apr; 116(3):e95-7. PubMed ID: 17126428
[TBL] [Abstract][Full Text] [Related]
6. Torsades de pointes with methadone.
Prescrire Int; 2005 Apr; 14(76):61-2. PubMed ID: 15875343
[TBL] [Abstract][Full Text] [Related]
7. QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone.
Kounas SP; Letsas KP; Sideris A; Efraimidis M; Kardaras F
Pacing Clin Electrophysiol; 2005 May; 28(5):472-3. PubMed ID: 15869686
[TBL] [Abstract][Full Text] [Related]
8. QT interval prolongation and torsade de pointes associated with indapamide. Comments to Letsas et al.
Perciaccante A; Fiorentini A
Int J Cardiol; 2007 Nov; 122(3):255; author reply 256-7. PubMed ID: 17368589
[No Abstract] [Full Text] [Related]
9. Ketoconazole induced torsades de pointes without concomitant use of QT interval-prolonging drug.
Mok NS; Lo YK; Tsui PT; Lam CW
J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1375-7. PubMed ID: 16403073
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced prolongation of the QT interval.
Cruciani RA; Portenoy RK; Homel P
N Engl J Med; 2004 Jun; 350(25):2618-21; author reply 2618-21. PubMed ID: 15208786
[No Abstract] [Full Text] [Related]
11. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
Ly T; Ruiz ME
Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
[TBL] [Abstract][Full Text] [Related]
12. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
Arbel Y; Swartzon M; Justo D
Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced torsades de pointes: a review of the Swedish pharmacovigilance database.
Aström-Lilja C; Odeberg JM; Ekman E; Hägg S
Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):587-92. PubMed ID: 18449951
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced long QT syndrome and torsade de pointes.
Morissette P; Hreiche R; Turgeon J
Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
[TBL] [Abstract][Full Text] [Related]
15. Schizophrenia, antipsychotic drugs, and cardiovascular disease.
Glassman AH
J Clin Psychiatry; 2005; 66 Suppl 6():5-10. PubMed ID: 16107178
[TBL] [Abstract][Full Text] [Related]
16. [QT interval prolongation and psychotropic drugs in children and adolescents: proposed guideline].
van Aerde KJ; Kalverdijk LJ; Reimer AG; Widdershoven JA
Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1765-70. PubMed ID: 18754307
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
Ahmad K; Dorian P
Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced prolongation of the QT interval.
Viskin S; Justo D; Zeltser D
N Engl J Med; 2004 Jun; 350(25):2618-21; author reply 2618-21. PubMed ID: 15208785
[No Abstract] [Full Text] [Related]
19. Drug-induced QT prolongation.
Tzivoni D
Isr Med Assoc J; 2001 Jun; 3(6):472. PubMed ID: 11433657
[No Abstract] [Full Text] [Related]
20. Methadone-associated QT prolongation and torsades de pointes. Dubrey and Groscott-Mason's patient was underttreated for her atrial fibrillation.
Al-Sardar H
Br J Hosp Med (Lond); 2007 Apr; 68(4):221; author reply 221. PubMed ID: 17469230
[No Abstract] [Full Text] [Related]
[Next] [New Search]
